Dr. Varaz Bozoghlanian, MD

Dr. Bozoghlanian practices at UCLA Medical Plaza in Los Angeles, California.

Dr. Bozoghlanian's NPI, 1174751382, was assigned on June 25, 2009. Dr. Bozoghlanian graduated from Medical College Of Wisconsin in 2009. Dr. Bozoghlanian holds California license A115637.

Dr. Bozoghlanian's primary practice is UCLA Medical Plaza, at 5767 W Century Blvd, Los Angeles, CA 90045 in Los Angeles County. The practice phone is (310) 794-1276.

Dr. Bozoghlanian's primary practice is UCLA Medical Plaza in Los Angeles, California. Dr. Bozoghlanian is also affiliated with Cedars-Sinai Medical Center. The medical group on file is Allergy Asthma Care Center, Inc. Dmand AI also links Dr. Bozoghlanian to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bozoghlanian practices, 2 sites in all. Vendor and product names are available with a free account.

Allergy and immunology is Dr. Bozoghlanian's primary specialty in the NPI Registry, under taxonomy code 207K00000X. Dr. Bozoghlanian is board certified in allergy & immunology by the American Board of Allergy and Immunology. Dr. Bozoghlanian is licensed in California.

Dmand AI lists asthma, chronic nasal allergies, chronic obstructive pulmonary disease (COPD), chronic sinusitis, contact dermatitis, ear eustachian tube disorders, hives and immune deficiency disease among the conditions Dr. Bozoghlanian treats.

CMS data shows 7,920 Medicare services from Dr. Bozoghlanian across 9 procedure codes in 2024, for 263 Medicare patients. Medicare paid $250,614 for them. Every service was in an office.

CMS counts 263 Medicare patients who saw Dr. Bozoghlanian in 2024. The largest group is 65 to 74, with 135 patients. 75% of them have high cholesterol, and 68% have high blood pressure. 10% are also on Medicaid. Their average risk score is 1.16, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bozoghlanian's median patient age at 53, with 69% women.

In 2024, Dr. Bozoghlanian wrote 1,067 Medicare Part D claims for 174 patients. 52% of them were for generic drugs. CMS names the drug for 821 of them, across 25 drugs with 11 or more claims each, at $766,790 in total drug cost. In 2023, CMS named 767 claims across 25 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Bozoghlanian for performance year 2024, reported individually. Dr. Bozoghlanian accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bozoghlanian as offering telehealth.

Dmand AI links 1 paper to Dr. Bozoghlanian in 2015. Dr. Bozoghlanian's most frequent co-authors are Ravi Gutta, MD, Heba Ismail, MD and Sharon Williams, MD.

CMS Open Payments shows 477 general payments to Dr. Bozoghlanian from 34 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 87% of the total. GlaxoSmithKline, LLC. paid the most, $1,462.

Dr. Bozoghlanian graduated from Medical College Of Wisconsin in 2009.

Dr. Bozoghlanian is in network with 13 carriers, including Blue Cross Blue Shield of Michigan, United Healthcare and Elevance. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.